Thursday, January 28, 2016 12:05:52 PM
Radiotherapy Market by Technology (External, Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product, & Application - Global Forecasts to 2020
The global radiotherapy market is expected to reach $7.5 billion by 2020 from $5.5 billion in 2015, at a CAGR of 6.2% between 2015 and 2020.
North America is expected to hold the largest share of the global radiotherapy market in 2015. By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.
Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.
Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.
Source:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices
The global radiotherapy market is expected to reach $7.5 billion by 2020 from $5.5 billion in 2015, at a CAGR of 6.2% between 2015 and 2020.
North America is expected to hold the largest share of the global radiotherapy market in 2015. By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.
Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.
Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.
Source:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
